Zoetis INC ZOETIS ORD SHS CLASS A
Zoetis INC ZOETIS ORD SHS CLASS A/ US98978V1035 /
0M3Q
|
07/11/2024 20:05:55
|
Var.
+3.22
|
Volume |
Denaro06:00:04 |
Lettera06:00:04 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
173.18USD
|
+1.89%
|
2,709
Fatturato: 465,124.41 |
-Quantità in denaro: - |
-Quantità in lettera: - |
78.62 bill.USD |
0.89% |
34.30 |
Descrizione business
Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Kristin Peck |
| Consiglio di amministrazione |
| Wetteny Joseph, Nick Ashton, Jamie Brannan, Heidi Chen, Rimma Driscoll, Jeannette Ferran Astorga, Roxanne Lagano, Wafaa Mamilli, Robert Polzer |
| Consiglio di sorveglianza |
| Michael McCallister, Paul M. Bisaro, Vanessa Broadhurst, Frank D’Amelio, Sanjay Khosla, Antoinette R. Leatherberry, Gregory Norden, Louise M. Parent, Kristin Peck, Dr. Willie M. Reed, Dr. Linda Rhodes, Robert Scully |
Dati aziendali
| Name: |
Zoetis Inc. |
| Indirizzo: |
10 Sylvan Way,Parsippany, New Jersey 07054, USA |
| Telefono: |
+1-973-822-7000 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.zoetis.com/ |
| Industria: |
Healthcare |
| Settore: |
Pharmaceutical Industry |
| Sub settore: |
Pharmaceuticals |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
83.54% |
| Data dell'IPO: |
01/02/2013 |
Rapporti con gli investitori
| Name: |
Steve Frank |
| IR telefono: |
+1-973-822-7141 |
| IR Fax: |
- |
| IR e-mail: |
steve.frank@zoetis.com
|
Company calendar
|
CW 49 | 03/12/2024
Dividend Payment
|
